- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03791437
Optimization of Chest Tube Drainage Management
February 14, 2024 updated by: Chang Gung Memorial Hospital
Optimization of Chest Tube Drainage Management to Shorten Postoperative Hospital Stay and Increase Satisfaction of Patients After Video-Assisted Thoracic Surgery
Early recovery after surgery was new developing science in recent years.
However , there was few reports in thoracic surgery field .
Investigators try to using digital chest drainage management system into the field of postoperative care and to see whether it could help patients to recovery from surgery as soon as possible.
According to investigators's clinical data collecting , investigators will establish a new postoperative care guideline for those patients who receive thoracic surgery
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Drainage of the space between the ribs and lungs has been practiced since the time of Hippocrates.
Thus far, the function of chest tubes, specifically to drain fluid or air from the pleural space, has virtually remained unchanged for more than 3000 years.
The use of chest drainage tubes after thoracic surgery is crucial to evacuate air leakage and/or pleural effusion; however, delayed tube removal may exacerbate pain, delay recovery of lung function and prolong hospitalization.
Recently, Thopaz digitally monitored thoracic drainage system (Medela Healthcare, Baar, Switzerland)has been designed to provide objective measurements of air leakage and pleural pressure.
With this system, air leakage and pleural pressure can be accurately measured in mL/min and mm H2O, respectively.
The rate of air leakage can be seen on a display in real time.
Digital surveillance for air leakage is reported to reduce interobserver disagreement in decision making in the management of patients with chest tubes, which might help caregiver a more solid evidence of strategies of postoperative chest drainage care.
Study Type
Interventional
Enrollment (Actual)
253
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taoyuan, Taiwan, 333
- Chang Gung Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Volunteer to join the study after thoroughly explanations
- Patient who received thoracoscope surgery for lung lesion
Exclusion Criteria:
- Not willing to join the study after thoroughly explanations
- Patients who have not received thoracoscope surgery for lung lesion
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experiment groups
Post chest operative use Digital chest drainage system until Patient's discharge day
|
patients who received Digital chest drainage system
|
|
Active Comparator: Control groups
Post chest operative use traditional drainage system until Patient's discharge day Not use Digital chest drainage system
|
patients who not received Digital chest drainage system( traditional drainage system)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Air leak graph of digital drainage system
Time Frame: Follow patient 's condition in OPD post surgery in two years
|
Compare Digital chest drainage system with traditional drainage system
|
Follow patient 's condition in OPD post surgery in two years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Days of hospital stay after surgery
Time Frame: Follow patient 's condition in OPD post surgery in two years
|
Compare Digital chest drainage system with traditional drainage system
|
Follow patient 's condition in OPD post surgery in two years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fluid graph of digital drainage system
Time Frame: Follow patient 's condition in OPD post surgery in two years
|
Compare Digital chest drainage system with traditional drainage system
|
Follow patient 's condition in OPD post surgery in two years
|
|
Patient Daily Activity
Time Frame: Until patient discharge from our hospital
|
Using Wearable Device for monitor patient's sleep quality and activity
|
Until patient discharge from our hospital
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Ching-Feng Wu, MD, Chang Gung Memorial Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2018
Primary Completion (Actual)
December 31, 2021
Study Completion (Actual)
December 31, 2023
Study Registration Dates
First Submitted
December 13, 2018
First Submitted That Met QC Criteria
December 28, 2018
First Posted (Actual)
January 2, 2019
Study Record Updates
Last Update Posted (Actual)
February 16, 2024
Last Update Submitted That Met QC Criteria
February 14, 2024
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CGMH-IRB-201701495A3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Diseases
-
Guangzhou Institute of Respiratory DiseaseUnknownInterstitial Lung Disease | Transbronchial Lung Cryobiopsy | Surgical Lung Biopsy
-
Bastiaan DriehuysNational Heart, Lung, and Blood Institute (NHLBI); University of Iowa; Children... and other collaboratorsCompletedInterstitial Lung DiseasesUnited States
-
Shanghai East HospitalRegend TherapeuticsCompletedInterstitial Lung DiseasesChina
-
Sohag UniversityNot yet recruitingInterstitial Lung Diseases
-
Aveiro UniversityFundação para a Ciência e a TecnologiaRecruitingInterstitial Lung DiseasesPortugal
-
RWTH Aachen UniversityCompletedObstructive Lung DiseasesGermany
-
China-Japan Friendship HospitalRecruitingTransbronchial Lung CryobiopsyChina
-
Matthias GrieseTerminatedInterstitial Lung Disease | Diffuse Parenchymal Lung Disease | Children´s Interstitial Lung DiseaseGermany
-
China-Japan Friendship HospitalXiangya Hospital of Central South University; Peking Union Medical College... and other collaboratorsUnknown
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedInterstitial Lung DiseasesNetherlands
Clinical Trials on Digital chest drainage system
-
IsalaCompletedPneumothorax and Air LeakNetherlands
-
University Hospital PadovaFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Monaldi Hospital; Vito Fazzi HospitalUnknown
-
Ospedali Riuniti AnconaThe University of Hong Kong; Yale University; The Leeds Teaching Hospitals NHS...Completed
-
Nova Scotia Health AuthorityCompletedPneumothorax | AtelectasisCanada
-
Peking University Third HospitalNot yet recruitingPrimary Spontaneous Pneumothorax
-
University of CalgarySunnybrook Health Sciences Centre; CHU de Quebec-Universite Laval; Université... and other collaboratorsCompletedPneumothoraxCanada
-
McMaster UniversityCompletedLung Neoplasms | Pleural EffusionCanada
-
University Hospital, Basel, SwitzerlandPfizer; Lancardis FoundationTerminatedComplicated Parapneumonic Effusion | Pleural EmpyemaGreece, Italy, Switzerland
-
University of PennsylvaniaCLR MedicalRecruiting
-
Taipei Medical University HospitalNational Science Council, TaiwanUnknown